1 / 3

Virility for men (yi li xiao capsule) contains an undeclared prescription drug and may pose serious health risks

Official notice

30 Jun 2025

Last checked

30 Jun 2025

Medium riskHealth Canada

An official Health Canada notice concerns Virility for men (yi li xiao capsule) contains an undeclared prescription drug and may pose serious health risks. Health Canada is warning consumers not to use Virility for Men (Yi Li Xiao Capsule) because it may pose serious health risks. The product was authorized as a natural health product to help enhance physical capacity/performance (in cases of physical stress), but recent Health Canada laboratory testing found it contains tadalafil, a prescription drug used to treat erectile dysfunction, which was not listed on the product label. Tadalafil is a prescription drug used to treat erectile dysfunction and should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) since it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss. Natural health products must not contain prescription drugs. Prescription drugs should be used only under the advice and supervision of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Health Canada has suspended the product licence for Virility for Men (Yi Li Xiao Capsule, NPN 80083930) and the licence holder Yexin Likang International Health Inc. Is recalling the product, which was distributed in Ontario. Health Canada is monitoring the effectiveness of the company’s recall and will take appropriate and timely action if any new health risks are identified. Published 2025-06-30.

What to do now

Stop using Virility for Men (Yi Li Xiao Capsule). Consult your health care professional if you have used this product and have health concerns. Report any health product-related side effects or complaints to Health Canada. Contact Yexin Likang International Health Inc. At frankzhangsap@yahoo.ca if you have questions about the recall.

Recall number

77660

Official notice

2025-06-30

The hazard

Health Canada is warning consumers not to use Virility for Men (Yi Li Xiao Capsule) because it may pose serious health risks. The product was authorized as a natural health product to help enhance physical capacity/performance (in cases of physical stress), but recent Health Canada laboratory testing found it contains tadalafil, a prescription drug used to treat erectile dysfunction, which was not listed on the product label. Tadalafil is a prescription drug used to treat erectile dysfunction and should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) since it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss. Natural health products must not contain prescription drugs. Prescription drugs should be used only under the advice and supervision of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Health Canada has suspended the product licence for Virility for Men (Yi Li Xiao Capsule, NPN 80083930) and the licence holder Yexin Likang International Health Inc. Is recalling the product, which was distributed in Ontario. Health Canada is monitoring the effectiveness of the company’s recall and will take appropriate and timely action if any new health risks are identified.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

77660

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Product - Virility for Men (Yi Li Xiao Capsule), NPN - 80083930, EXP Date - 2026/12

Risk / hazard

Health Canada is warning consumers not to use Virility for Men (Yi Li Xiao Capsule) because it may pose serious health risks. The product was authorized as a natural health product to help enhance physical capacity/performance (in cases of physical stress), but recent Health Canada laboratory testing found it contains tadalafil, a prescription drug used to treat erectile dysfunction, which was not listed on the product label. Tadalafil is a prescription drug used to treat erectile dysfunction and should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerine) since it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss. Natural health products must not contain prescription drugs. Prescription drugs should be used only under the advice and supervision of a healthcare professional because they are used to treat specific conditions and may cause serious side effects. Health Canada has suspended the product licence for Virility for Men (Yi Li Xiao Capsule, NPN 80083930) and the licence holder Yexin Likang International Health Inc. Is recalling the product, which was distributed in Ontario. Health Canada is monitoring the effectiveness of the company’s recall and will take appropriate and timely action if any new health risks are identified.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Virility For Men.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

App estimate

medium

Recall details

Recall number

77660

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
No image published for this recall

Hotline IV fluid warmer system & accessories

High riskHealth Canada6 Jul 2026
CA
No image published for this recall

Hybrid hydrophilic microguidewire

Medium riskHealth Canada3 Jul 2026
CA
No image published for this recall

Intramedullary bone saw blade assembly

Medium riskHealth Canada3 Jul 2026
CA
No image published for this recall

Abiomed introducer kits with impella heart pumps

High riskHealth Canada29 Jun 2026
CA
Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)Image: Health Canada recall notice

Importation of chinese-authorized ifosfamide for injection due to the current shortage of canadian-authorized ifex (ifosfamide for injection)

Medium riskHealth Canada22 Jun 2026
CA
No image published for this recall

Bd maxplus ™ connector minibore extension set

High riskHealth Canada19 Jun 2026
CA
No image published for this recall

Med-Rx wound care kit

Medium riskHealth Canada18 Jun 2026
CA
No image published for this recall

Halyard* purezero* ultraviolet* nitrile exam gloves

Medium riskHealth Canada17 Jun 2026
CA
No image published for this recall

Corneat kpro

Medium riskHealth Canada17 Jun 2026
CA
No image published for this recall

Ge healthcare integrated and stand-alone resuscitation systems

Medium riskHealth Canada16 Jun 2026
CA
No image published for this recall

Unauthorized soft-shelled hyperbaric chambers may pose serious health risks 2026-06-16

Critical riskHealth Canada16 Jun 2026
CA
No image published for this recall

Giraffe™ omnibed™ carestation™

Medium riskHealth Canada4 Jun 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 30 Jun 2025. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.